Torres‐Torres, J., Villafán‐Bernal, J., De Leon‐Carbajal, J., Hawkins‐Villarreal, A., Murillo‐Bargas, H., Medina‐Jimenez, V., . . . Martinez‐Portilla, R. (2020). VP45.29: Effectiveness of low‐dose hydroxychloroquine versus placebo for the prevention of severe pneumonia in pregnant women with SARS‐CoV2 infection: PROTOCOL for a randomised controlled trial (HYPREG trial). Ultrasound Obstet Gynecol.
Chicago Style CitationTorres‐Torres, J., J. Villafán‐Bernal, J. De Leon‐Carbajal, A.M Hawkins‐Villarreal, H. Murillo‐Bargas, V. Medina‐Jimenez, R.A. Gurrola Ochoa, C. Celis‐González, i R.J Martinez‐Portilla. "VP45.29: Effectiveness of Low‐dose Hydroxychloroquine Versus Placebo for the Prevention of Severe Pneumonia in Pregnant Women With SARS‐CoV2 Infection: PROTOCOL for a Randomised Controlled Trial (HYPREG Trial)." Ultrasound Obstet Gynecol 2020.
Cita MLATorres‐Torres, J., et al. "VP45.29: Effectiveness of Low‐dose Hydroxychloroquine Versus Placebo for the Prevention of Severe Pneumonia in Pregnant Women With SARS‐CoV2 Infection: PROTOCOL for a Randomised Controlled Trial (HYPREG Trial)." Ultrasound Obstet Gynecol 2020.